Wu H - Search Results

1

Splicing Factor DDX23, Transcriptionally Activated by E2F1, Promotes Ovarian Cancer Progression by Regulating FOXM1.

Zhao C, Li Y, Qiu C, Chen J, Wu H, Wang Q, Ma X, Song K, Kong B. Zhao C, et al. Among authors: wu h. Front Oncol. 2021 Dec 13;11:749144. doi: 10.3389/fonc.2021.749144. eCollection 2021. Front Oncol. 2021. PMID: 34966670 Free PMC article.

2

PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.

Ma H, Li Y, Wang X, Wu H, Qi G, Li R, Yang N, Gao M, Yan S, Yuan C, Kong B. Ma H, et al. Among authors: wu h. Cell Death Dis. 2019 Feb 18;10(3):166. doi: 10.1038/s41419-019-1415-6. Cell Death Dis. 2019. PMID: 30778048 Free PMC article.

3

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.

Wu H, Li R, Zhang Z, Jiang H, Ma H, Yuan C, Sun C, Li Y, Kong B. Wu H, et al. J Ovarian Res. 2019 Dec 29;12(1):125. doi: 10.1186/s13048-019-0601-6. J Ovarian Res. 2019. PMID: 31884974 Free PMC article.

4

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.

Wu H, Li R, Zhang Z, Jiang H, Ma H, Yuan C, Sun C, Li Y, Kong B. Wu H, et al. J Ovarian Res. 2020 Mar 13;13(1):28. doi: 10.1186/s13048-020-00628-5. J Ovarian Res. 2020. PMID: 32169110 Free PMC article.

5

Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma.

Zhang Z, Sun C, Li C, Jiao X, Griffin BB, Dongol S, Wu H, Zhang C, Cao W, Dong R, Yang X, Zhang Q, Kong B. Zhang Z, et al. Among authors: wu h. Front Oncol. 2020 Apr 22;10:453. doi: 10.3389/fonc.2020.00453. eCollection 2020. Front Oncol. 2020. PMID: 32391256 Free PMC article.

6

IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer.

Dongol S, Zhang Q, Qiu C, Sun C, Zhang Z, Wu H, Kong B. Dongol S, et al. Among authors: wu h. Oncol Lett. 2020 Aug;20(2):1179-1192. doi: 10.3892/ol.2020.11664. Epub 2020 May 21. Oncol Lett. 2020. PMID: 32724358 Free PMC article.

7

FBLN5 is targeted by microRNA‑27a‑3p and suppresses tumorigenesis and progression in high‑grade serous ovarian carcinoma.

Li R, Wu H, Jiang H, Wang Q, Dou Z, Ma H, Yan S, Yuan C, Yang N, Kong B. Li R, et al. Among authors: wu h. Oncol Rep. 2020 Nov;44(5):2143-2151. doi: 10.3892/or.2020.7749. Epub 2020 Sep 3. Oncol Rep. 2020. PMID: 32901854 Free PMC article.

8

Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer.

Wang Q, Ma X, Wu H, Zhao C, Chen J, Li R, Yan S, Li Y, Zhang Q, Song K, Yuan C, Kong B. Wang Q, et al. Among authors: wu h. Oncoimmunology. 2022 Jul 1;11(1):2096362. doi: 10.1080/2162402X.2022.2096362. eCollection 2022. Oncoimmunology. 2022. PMID: 35800156 Free PMC article.

9

Clinical features and prognostic factors analysis of intravenous leiomyomatosis.

Chen J, Bu H, Zhang Z, Chu R, Qi G, Zhao C, Wang Q, Ma X, Wu H, Dou Z, Wang X, Kong B. Chen J, et al. Among authors: wu h. Front Surg. 2023 Jan 30;9:1020004. doi: 10.3389/fsurg.2022.1020004. eCollection 2022. Front Surg. 2023. PMID: 36793517 Free PMC article.

10

Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8⁺ T cell exhaustion via TRIM14-IFN-β axis.

Ma X, Wang Q, Sun C, Agarwal I, Wu H, Chen J, Zhao C, Qi G, Teng Q, Yuan C, Yan S, Peng J, Li R, Song K, Zhang Q, Kong B. Ma X, et al. Among authors: wu h. Cell Rep. 2023 Aug 29;42(8):112944. doi: 10.1016/j.celrep.2023.112944. Epub 2023 Aug 10. Cell Rep. 2023. PMID: 37566545 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,560 results

Search Page

Filters